Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

6.78
Delayed Data
As of May 04
 -0.10 / -1.45%
Today’s Change
4.32
Today|||52-Week Range
7.98
+6.10%
Year-to-Date
No recent news for Compugen Ltd.

Today’s Trading

Previous close6.88
Today’s open6.76
Day’s range6.65 - 6.83
Volume148,613
Average volume (3 months)131,911
Market cap$347.9M
Dividend yield--
Data as of 3:59pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-73.91%
Earnings growth (this year)-13.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.99%
P/E ratioNM
Price/Sales34.74
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-1.20-7.71%
QUREUniqure NV-1.22-9.11%
NDRMNeuroderm Ltd-0.28-1.65%
VYGRVoyager Therapeutics...-0.04-0.33%
Data as of 3:59pm ET, 05/04/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$9.3M
Annual profit (last year)-$20.2M
Net profit margin-217.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Financial Officer
Ari Krashin
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers

Search for Jobs